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RESEARCH ARTICLE
Indian Parents Prefer Vaccinating their Daughters against
HPV at Older Ages
Purnima Madhivanan1,2*, Vijaya Srinivas2, Laura Marlow3, Soumyadeep
Mukherjee1, Doddaiah Narayanappa4, Shekar Mysore5, Anjali Arun2, Karl
Krupp1,2
Abstract
Background: Increasing uptake of human papillomavirus (HPV) vaccine should be a priority in developing
countries since they suffer 88% of the world’s cervical cancer burden. In many countries studies show that age
at vaccination is an important determinate of parental acceptability. This study explores parental preferences
on age-to-vaccinate for adolescent school-going girls. Materials and Methods: The sample was selected using a
two-stage probability proportional to size cluster sampling methodology. Questionnaires were sent home with a
random sample of 800 adolescent girls attending 12 schools in Mysore to be completed by parents. Descriptive
statistics including frequencies, percentages and proportions were generated for independent variables and
bivariate analyses (Chi square test) were used to assess the relationship between independent and appropriate
age-to-vaccinate. Results: HPV vaccination acceptability was high at 71%. While 5.3% of parents felt girls
should be vaccinated by 10 years or younger; 38.3% said 11-15 years; 14.8% said 16-18 years; 5.8% suggested
over 19 years; and 33% didn’t know. Only 2.8% of parents would not vaccinate their daughters. Conclusions:
'HOD\LQJ+39YDFFLQDWLRQXQWLOODWHUDJHVPD\VLJQLÀFDQWO\LQFUHDVHXSWDNHRIWKH+39YDFFLQHLQ,QGLD
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Introduction
Cervical cancer is a major cause of death among
women in developing countries where it accounts for
about 13% of all female cancers (Globocan, 2008).
The disease has largely been eliminated in high income
countries with prophylactic immunization and secondary
prevention (Gakidou et al., 2008; Demarteau et al., 2012).
Introduction of the HPV vaccine has proceeded slowly
in many countries because of low knowledge about
cervical cancer, high vaccine cost, and cultural preferences
surrounding vaccinating young girls (Tsui et al., 2009).
HPV types 16 and/or 18, against which the vaccines are
most effective (CDC, 2012), have been found to be present
in 74% to nearly 90% of cervical cancer patients in India.
(Basu et al., 2009; Das, 2013). Estimates suggest that
prophylactic HPV vaccination can reduce the burden of
cervical cancer in India by more than 75% (Basu et al.,
2009). According to the results of a cost-effectiveness
analysis, 70% coverage of pre-adolescent girls (girls below

age 12) with the HPV vaccine can potentially reduce
the lifetime risk of cervical cancer by 44%; and is more
effective than screening alone. Screening three times in a
lifetime reduces cervical cancer risk by 21-33% (Diaz et
al., 2008). Despite these facts, little research on vaccine
acceptability has been carried out in India, a country with
one of the highest incidence of cervical cancer in the
world.
Studies have shown that age-at-vaccination is an
important factor in parental decision-making about
immunizing daughter against HPV infection (Marlow
et al., 2007). A qualitative study carried out in the
same population suggested that many parents preferred
vaccinating girls against HPV after puberty. Most felt
that younger girls were unlikely to be sexually active and
therefore should not receive an HPV vaccination until
they were adolescents or young adults (Madhivanan et
al., 2009). This manuscript describes a quantitative survey
among parents of school going girls in urban Mysore about
the most appropriate age at HPV vaccination.
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Materials and Methods
Between February and December 2010, a questionnaire
survey was conducted among parents in a cluster of 12
schools Mysore City, India. Participants were included if
they had an adolescent school-going daughter (ages 1115) in target schools; were able to read and understand
English or Kannada, the local language; and could give
informed consent.
A program announcement was sent home with all
girls attending 7th through 10th grades explaining the
study and inviting eligible parents to participate. Then
we enumerated all schoolgirls in the target age group and
randomly selected 800 female students to take surveys
home. The questionnaire that it should be completed
by one parent per household and returned within seven
days. The study was approved by the Institutional Review
Committee of Public Health Research Institute of India
and Florida International University.
Data were analyzed using Stata 10.1 (Stata Corporation,
College Station, TX) and SAS statistical software package,
version 9.3 (SAS Institute Inc., Cary, North Carolina).
Issues related to cluster sampling was adjusted by using


      























 
   


 

        
 
 


Figure 1. Distribution of Parents (N=778) According
to the Age at which they Prefer Girls should Receive
HPV Vaccine

“proc surveyfreq” procedures. Descriptive statistics were
conducted for all variables. Bivariate associations between
preferred ‘age-of-vaccination’ and explanatory variables
ZHUHDVVHVVHGXVLQJFKLVTXDUHGWHVWV7HVWVRIVLJQLÀFDQFH
were 2-tailed (p<0.05).

Results
Of the 797 returned surveys, 19 were excluded from
analyses because they were returned without a signed
consent form. 298 parents (about 38.3%) preferred
vaccinating their daughters between 11-15 years; 5.3%,
10 years or younger; 20.6% favored late vaccination (16
years or older) and 33% were unsure when to vaccinate
(Figure 1).
Of the 43.6% of parents who thought the appropriate
age to vaccinate was less than 15 years, 81% were likely to
accept HPV vaccination for their daughter as compared to
70% of those who thought the appropriate age to vaccinate
was over 15 years of age. Interestingly, of the 35.9%
of respondents who were unsure of appropriate age-tovaccinate, 60.6% also found HPV vaccination acceptable.
Table 1 describes the relationship of the demographic
characteristics of the respondents with their preferred age
of vaccination of girls with HPV vaccine. About 41%
of Hindus, 51% Muslims and 64% of parents of other
religions said they would consider early vaccination for
their daughters (p=0.0009). There was no association with
age-at-vaccination and other demographic characteristics
of respondents.
Age to discuss HPV and cancer with daughters
Parents were asked the most appropriate age when they
would discuss cancer with their daughters and cervical
FDQFHUVSHFLÀFDOO\:KLOHRISDUHQWVZHUHZLOOLQJ

Table 1. Relationship of Demographic Characteristics Associated with Parents’ Preferred age at HPV Vaccination
of Children (N =778) in Mysore City, India
Preferred age of vaccination (n= 778)
Total (%)d
a
b
c
15 or less (%) Above 15 (%)
Not sure (%)

Characteristic
$JHJURXS \HDUV 

Education level

Employment Status

Marital Status
Religion


36-40
41-50
51-60
None
1 to10th grade
High School & Bachelor degree
Master degree or above
Vocational Training (Diploma)
Employed full time
Employed part-time
Self-employed
Full time home maker
Retired/Unemployed
Married
Divorced/Separated/widowed
Hindus
Muslim
Christians/ others

  
126 (49.0)
65 (41.4)
46 (37.7)
53 (45.7)
167 (42.4)
88 (46.6)
15 (38.5)
16 (40.0)
91 (42.5)
36 (43.4)
52 (46.4)
147 (43.4)
13 (43.3)
321 (43.6)
18(43.9)
249 (41.0)
74 (50.7)
16(64.0)

  
47 (18.3)
34 (21.7)
33 (27.0)
24 (20.7)
80 (20.3)
35 (18.5)
13 (33.3)
8 (20.0)
47 (22.0)
18 (21.7)
19 (17.0)
73 (21.5)
3 (10.0)
150 (20.4)
10 (24.4)
130 (21.4)
27 (18.5)
3(12.0)

  
84 (34.71)
58 (36.9)
43 (35.2)
39 (33.6)
147 (37.3)
66 (34.9)
11 (28.2)
16 (40.0)
76 (35.5)
29 (34.9)
41 (36.6)
119 (35.1)
14 (46.7)
266 (36.1)
13 (31.7)
228 (37.6)
45 (30.8)
6(24.0)

  
257 (32.7)
157 (20.2)
122 (15.7)
116 (14.9)
394 (50.6)
189 (24.3)
39 (5.0)
40 (5.1)
214 (27.5)
83 (10.7)
112 (14.4)
339 (43.6)
30 (3.9)
737 (94.7)
41 (5.3)
607 (78.0)
146 (18.8)
25 (3.2)

Chi-Square
p value


0.41

0.82

0.81
0.0009*

VWDWLVWLFDOO\VLJQLÀFDQW aproportion of the parents within each category who prefer that age at HPV vaccination should be 15 years or less, bproportion of the parents
within each category who prefer that age at HPV vaccination should be above 15 years, cproportion of the parents within each category, who are not sure of an appropriate
age for HPV vaccination, bpercentage out of the total (N=778)
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WRGLVFXVVFDQFHULQJHQHUDOZLWK\RXQJHUGDXJKWHUV 
years); 25% of the parents were willing to discuss with
daughters aged 11-14 years; and 35% between 15-18
years. About 29% reported that girls should be over 18
years before cancer is discussed. In contrast, only 3% were
ZLOOLQJWRGLVFXVVFHUYLFDOFDQFHUVSHFLÀFDOO\ZLWKWKHLU
\RXQJHUDJHGDXJKWHUV$ERXWRQHLQÀYHZRXOGGLVFXVVLW
with 11-14 year olds, and 34% felt it was only appropriate
for 15-18 year olds. Over 40% of the parents preferred
discussing cervical cancer only if daughters were over 19
years of age.
 :KHQDVNHGLISDUHQWVZRXOGGLVFXVVVH[LQJHQHUDO
DQGVH[XDOO\WUDQVPLWWHGLQIHFWLRQVVSHFLÀFDOO\PRUHWKDQ
half of the sample (60%) preferred waiting until their
daughter was 19 years or older. About a third (30.1%) of
participants reported they would consider talking to their
child when she is 15-18 years of age.
Parents were asked about the appropriate time for
discussing vaccinations in general, and HPV vaccination
in particular, with their daughter. About one in five
(20%) and one in 10 respectively were willing to discuss
vaccinations in general and HPV vaccination with their
younger age daughters. Less than one third of parents
(27%) and 29% respectively, said they would talk to
their 11-14 years about vaccination in general and HPV
YDFFLQDWLRQVSHFLÀFDOO\$ERXWDQGVDLGWKH\
would talk to their 15-18 years about vaccinations in
general and HPV vaccination in particular, respectively.
Finally, 19% and 21% said they would only discuss
vaccinations in general and HPV vaccine in particular
with a daughter over age 19.
Information about vaccinations
Most parents (85%) reported television as their main
way of getting information about vaccines; 79% said
newspaper or radio; and 43%, the internet. In addition,
86% of the parents reported doctors as their main source
of information about vaccines; 60%, friends or neighbors;
and 54%, other healthcare workers. A vast majority (82%)
reported getting information from their daughter’s school
on vaccinations, and 63% said they relied on family
members or relatives for this information.

Discussion
7KLV VWXG\ LV RQH RI WKH ÀUVW WR H[DPLQH SDUHQWDO
preferences about age of vaccination for HPV infection
in southern India. The data shows that majority of parents
felt that daughters should be vaccinated at older ages (11 :KLOHRIUHVSRQGHQWVDOVRIHOWWKDWFDQFHUDQG
cervical cancer should not be discussed with a child until
they are older (15-19 years). Finally, many parents receive
their vaccine information from television (84.5%), or a
family physician (86%).
The preference for vaccinating older children should
not be overlooked in planning a rollout of the HPV
YDFFLQH6LQFHWKHDYHUDJHDJHDWÀUVWLQWHUFRXUVHLV
years in India, immunizing at later ages is unlikely to
reduce the effectiveness of the vaccine (Durex Network ,
2007). Our data shows that Indian parents would be more
accepting of HPV immunization if it were given at later

DJHV7KLV LV VLPLODU WR ÀQGLQJV IURP UHVHDUFK LQ RWKHU
countries, where, some studies have revealed parental
willingness to vaccinate an older child compared to a
younger one (Dempsey et al., 2006; Zhang et al., 2013).
Results of the study also suggest the importance of
educating Pediatricians and Family physicians about HPV
and cervical cancer. In addition, since a large percentage
of parents get their information from television (85%) and
the internet (43%), the vaccine should be aggressively
promoted in these mediums.
This study had several limitations. First, because
it utilized a sample of only parents of school-going
DGROHVFHQW JLUOV ÀQGLQJV PD\ QRW EH UHSUHVHQWDWLYH RI
the population as a whole. Even among parents of schoolgoing children, certain segments of the population may
not have been represented in the institutions selected for
study. The study also has important strengths including a
high response rate, minimal missing data and a randomly
selected study population. In conclusion, our study
found Indian parents would be more accepting of HPV
immunization if it were given at later ages. More studies
are needed to examine parental acceptability and preferred
age-to-vaccinate in different populations in India.
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